We have a group of outstanding employees who are honest, happy, healthy, and enthusiastic.
We have a win-win platform that features respect, transparency, openness, and cooperation.
We have innovative scientific research and efficient management.
We give priority to potential rather than ability or experience.
.jpg)
People are one of our core assets. We are committed to providing competitive
Comprehensive sa lary and benefits plans, and appealing welfare and incentive plans, in a bid to enhance the cohesion and sense of belonging of employees, and advocate work-life balance.
Pre-clinical R&D
Senior Director Wangyang Tu
Joined Haihe in December 2020
After working in both domestic and global pharmaceutical companies for a decade, differentiating understanding and thoughts about drug discovery has accumulated in my mind. Choosing HaiHe as next step of my career, is simply driven by the strong, trustworthy, science-driven leadership team of HaiHe. With China Academy of Engineering member Dr. Ding Jian, experienced clinical development expert Dr. Dong Ruiping to steer the discovery strategies, and drug discovery veteran Dr. Li Leping to lead preclinical discovery and early development tasks, I am more than happy to work with our medicinal chemistry teams, to try our best, to deliver the most efficacious drugs to patients as early as we can.
Senior Director
Pre-clinical R&D Bing Yu
Joined Haihe in November 2020
Before joining in Haihe Biopharma, I have conducted drug development in academia, multi-national pharmaceutical and startup biotech companies for 12 years after PhD training. The founder and senior management team of Haihe Biopharma created this company for real innovate drug development, with a dream of providing better therapeutics to patients and doctors, which attracts me to select this company for my next career step. Herein, I integrated my career goal with our company development, experienced every single progressing step of all the innovative drugs and achieved my own career development. I truly believe that we will keep growing to realize the dream of innovate drugs.
Associate Director of the
Clinical Science & Strategy Department Lei Yang
Joined Haihe in 2018
I used to be a physician in a top-tier hospital. It has always been my ambition to treat illnesses and save people. I joined Haihe with the hope to develop more new drugs for the treatment of patients.
Four years ago, I listened to Academician Jian Ding’s lecture in the Shanghai Science Hall. At that time, I was deeply impressed by the work done by Academician Ding and his team, and was moved by the vision of ‘developing affordable high-quality drugs for the Chinese people, and launching China’s innovative drugs globally’. I was very fortunate to join Haihe Biopharma founded by Academician Ding. I hope to work with the company to make contribution to the research and development of new drugs in China. Academician Ding is a scientist and leader with a strong feeling of love and duty for the nation. He has been exploring new anti-tumor drugs for decades. He is determined to deliver on the mission to accelerate the clinical use of innovative drugs independently developed by China, with an aim to make quality drugs affordable to Chinese people, and promote these China-developed original drugs on the global stage.
